Ozurdex Reduced Inflammation, Improved Visual Acuity in Uveitic Eyes
The Ozurdex dexamethasone intravitreal implant
(Allergan, Inc.) significantly improved intraocular inflammation
and visual acuity in patients with noninfectious
intermediate or posterior uveitis, according to a study in
the Archives of Ophthalmology.1
The 26-week, prospective, multicenter, masked study
included 229 pa...